John Dunlop

John Dunlop is an accomplished executive in the field of neuroscience with extensive experience in both research and leadership roles. Currently serving as Chief Scientific Officer at Aliada Therapeutics since September 2023, Dunlop previously held the position of Head of Research & Development and Chief Scientific Officer at Neumora from March 2020 to September 2023. Prior to that, Dunlop was Vice President at Amgen from September 2016 to October 2021, and held multiple senior roles at AstraZeneca, including Vice President and Head of Neuroscience Innovative Medicines. Dunlop also served as Chief Operating Officer and other senior positions at Pfizer between April 2003 and March 2012. Educationally, Dunlop earned a PhD in Neuroscience from the University of St Andrews and a BSc in Biochemistry from the University of Glasgow.